MEOBF - Mesoblast: Back Pain And Heart Failure Remain Option Value, Not Base Case October, 07 2025 02:57 PM Mesoblast Ltd Ord 2025-10-07 14:57:04 ET Introduction Mesoblast’s stock ( MESO ) is up 70% since my rating upgrade from Sell to Hold in July 2025.... For further details see: Mesoblast: Back Pain And Heart Failure Remain Option Value, Not Base Case